1. Home
  2. LPA vs IMA Comparison

LPA vs IMA Comparison

Compare LPA & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPA
  • IMA
  • Stock Information
  • Founded
  • LPA 2013
  • IMA 2019
  • Country
  • LPA United States
  • IMA United States
  • Employees
  • LPA N/A
  • IMA N/A
  • Industry
  • LPA
  • IMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • LPA
  • IMA Health Care
  • Exchange
  • LPA Nasdaq
  • IMA Nasdaq
  • Market Cap
  • LPA 196.1M
  • IMA 159.1M
  • IPO Year
  • LPA N/A
  • IMA N/A
  • Fundamental
  • Price
  • LPA $6.31
  • IMA $8.35
  • Analyst Decision
  • LPA
  • IMA
  • Analyst Count
  • LPA 0
  • IMA 0
  • Target Price
  • LPA N/A
  • IMA N/A
  • AVG Volume (30 Days)
  • LPA 10.2K
  • IMA 48.0K
  • Earning Date
  • LPA 11-12-2025
  • IMA 11-15-2025
  • Dividend Yield
  • LPA N/A
  • IMA N/A
  • EPS Growth
  • LPA N/A
  • IMA N/A
  • EPS
  • LPA 0.22
  • IMA N/A
  • Revenue
  • LPA $45,924,457.00
  • IMA $4,300,000.00
  • Revenue This Year
  • LPA N/A
  • IMA N/A
  • Revenue Next Year
  • LPA N/A
  • IMA N/A
  • P/E Ratio
  • LPA $29.31
  • IMA N/A
  • Revenue Growth
  • LPA 6.18
  • IMA N/A
  • 52 Week Low
  • LPA $5.71
  • IMA $7.95
  • 52 Week High
  • LPA $15.85
  • IMA $23.28
  • Technical
  • Relative Strength Index (RSI)
  • LPA 49.52
  • IMA N/A
  • Support Level
  • LPA $6.10
  • IMA N/A
  • Resistance Level
  • LPA $6.62
  • IMA N/A
  • Average True Range (ATR)
  • LPA 0.25
  • IMA 0.00
  • MACD
  • LPA 0.01
  • IMA 0.00
  • Stochastic Oscillator
  • LPA 52.31
  • IMA 0.00

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

About IMA ImageneBio Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

Share on Social Networks: